Unbiased AI-powered news
Federal agencies began enhanced screening and entry restrictions on May 18, 2026, to limit the risk of Ebola disease caused by Bundibugyo virus entering the United States. The measures target travelers from Uganda, the Democratic Republic of the Congo, and South Sudan.
vox.comFederal agencies began enhanced screening and entry restrictions on May 18, 2026, to limit the risk of Ebola disease caused by Bundibugyo virus entering the United States. The Centers for Disease Control and Prevention, the Department of Homeland Security, and other federal agencies are applying the measures under authority from Sections 362 and 365 of the Public Health Service Act.
The order will remain in effect for 30 days.
Enhanced screening and traveler monitoring will apply to individuals arriving from affected areas. Non-U.S. Agencies will coordinate with airlines and port-of-entry officials to identify and manage travelers who may have been exposed. Port health protection, contact tracing, laboratory testing capacity, and hospital readiness will also be strengthened nationwide.
CDC assesses the immediate risk to the general U.S. public as low. Officials will continue to evaluate the situation and may adjust measures as new information becomes available. Travelers from affected countries are advised to monitor their health for 21 days after travel and seek medical care immediately if they develop fever, weakness, vomiting, diarrhea, or unexplained bleeding.
Single source — no framing comparison available.
theepochtimes.comThe Food and Drug Administration approved enlicitide, sold as Lipfendra, on Thursday. The daily pill inhibits PCSK9 and carries a lower list price than existing injectable treatments.
news.ycombinator.comKalshi will allow bets on selected clinical trial results and full FDA decisions, starting with Phase 3 studies from established companies. The FDA separately approved Merck's Lipfendra cholesterol pill based on studies showing up to 60% LDL reduction.
The IndependentThe Joint Committee on Vaccination and Immunisation advised adding a teenage booster dose to the national schedule. The change follows an outbreak in Kent that killed two teenagers earlier in 2026.